ConductScience.org, home

Trial · NCT06459310

Pilot Study on Evaluating the Geroprotective Effect of Metformin

NCT06459310, Phase 2, Recruiting, Xuanwu Hospital, Beijing

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Pilot Study on Evaluating the Geroprotective Effect of Metformin. Trials, record NCT06459310. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06459310

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Pilot Study on Evaluating the Geroprotective Effect of Metformin
NCT number
NCT06459310
Status
Recruiting
Phases
Phase 2
Enrollment
130 participants, estimated
Lead sponsor
Xuanwu Hospital, Beijing
Conditions
Metformin, Aging
Interventions
Metformin Hydrochloride tablet, Placebo
First posted
2024-06-14
Last updated
2025-03-21

Source ClinicalTrials.gov

Registered outcomes2

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryComposite the efficacy of metformin in intervening agingBaseline - 12 month
1. Metformin delay aging related sensitive indicators (2), such as SA\*, ancient virus \*. 2. Metformin inhibits markers of inflammation in the body (4), such as C1 protein \*, CRP, CXCL9, TNFa. 3. Metformin improved immune cell-related indicators (10\*), such as T1/T2/L gene expression. 4. Metformin improves metabolism-related indexes (4), such as metabolic secretion factors APOX1\* and APOX2\*. 5. Age-related indicators have been published (5), such as telomere length, DNA methylation age, hormone levels, etc.
SecondaryComposite Through clinical physical examination data, behavioral indicators and multilevel omics data, to discover new sensitive biomarkers for evaluating aging.Baseline - 12 month
1. Aging atlas-R, PBMC RNA profiling, \>5% DEGs. 2. Aging atlas-P, proteomic profiling, \>5% DEPs. 3. Aging atlas-M, metabolic profiling, \>5% metabolites. 4. Aging atlas-B, metagenomic profiling, \>5% microbiotas. 5. Reduce human biological age complex parameters.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers14

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
9428832BACKGROUNDPubMed
20415693BACKGROUNDPubMed
22540912BACKGROUNDPubMed
23540700BACKGROUNDPubMed
23900241BACKGROUNDPubMed
24080598BACKGROUNDPubMed
25456737BACKGROUNDPubMed
31216464BACKGROUNDPubMed
31585093BACKGROUNDPubMed
31944526BACKGROUNDPubMed

1 to 10 of 14

See all 14 papers

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT06459310

GET https://conductscience.org/api/trials/v1/NCT06459310/registered